Filter
187
Text search:
monoclonal
antibodies
Featured
Recommendations
30
New Publications
32
Language
Document type
No document type
70
Guidelines
49
Studies & Reports
29
Manuals
17
Fact sheets
8
Strategic & Response Plan
5
Training Material
3
Resource Platforms
3
Situation Updates
2
Infographics
1
Countries / Regions
Global
17
India
14
South Africa
6
Germany
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
Philippines
3
Syria
3
Venezuela
3
Mali
2
Niger
2
Pakistan
2
Afghanistan
2
West and Central Africa
2
Middle East and North Africa
2
Africa
2
Russia
2
France
2
Spain
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Ethiopia
1
Cameroon
1
Uganda
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Chad
1
Tanzania
1
Rwanda
1
Mauritania
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
Namibia
1
Peru
1
Brazil
1
North Macedonia
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Western and Central Europe
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
41
Clinical Guidelines
31
Public Health
14
Pharmacy & Technologies
9
Women & Child Health
6
Capacity Building
2
Key Resources
2
Toolboxes
COVID-19
53
NTDs
13
Ebola & Marburg
12
HIV
10
NCDs
9
Malaria
9
Rapid Response
8
Polio
6
Pharmacy
5
Health Financing Toolbox
5
AMR
4
Cholera
3
Zika
3
Planetary Health
3
2.0 Rapid Response
3
Mental Health
2
Conflict
1
Natural Hazards
1
Refugee
1
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
Responding to a poliovirus event and outbreak, Part 1: General (SOPs) describes the general principles and steps to facilitate timely and effective responses to poliovirus events and outbreaks, and incorporate lessons learned from recent previous outbreak response efforts. This document summarizes r
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
16.7.2021
4th edition
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influenza A) viruses.
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change.
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us
...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite
...
